摘要

This report describes how a bivalent mRNA booster dose provided additional protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2-4 monovalent vaccine doses.

詳細內容

This report describes how a bivalent mRNA booster dose provided additional protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2-4 monovalent vaccine doses.

關鍵發現

(需要透過 WebFetch 補充或人工審核來提取關鍵發現)

---

萃取時間: 2026-02-05T15:11:29Z 資料來源: CDC MMWR